8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Oct 20, 2009)

Filed October 20, 2009For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on October 20, 2009, to report its financial results for the third quarter ended September 30, 2009. The filing primarily consists of a press release announcing these results, which is incorporated by reference. Investors can find details regarding the company's performance during the quarter within this attached press release. While the 8-K itself is brief and serves as a notification of the results, the core information for investors lies in the referenced press release (Exhibit 99.1). This document would typically contain key financial metrics such as revenue, earnings per share (EPS), and any significant operational updates or management commentary that influenced the quarter's performance. Investors should refer to Exhibit 99.1 for a comprehensive understanding of Quest Diagnostics' financial condition and operational results for the period.

Key Highlights

  • 1Quest Diagnostics (DGX) filed an 8-K on October 20, 2009.
  • 2The filing announces the company's financial results for the third quarter ended September 30, 2009.
  • 3The primary content of the 8-K is a press release containing these financial results.
  • 4The press release is attached as Exhibit 99.1 and is incorporated by reference.
  • 5Investors should review Exhibit 99.1 for detailed financial performance and operational updates.
  • 6The report was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Quest Diagnostics Incorporated's financial results for the third quarter ended September 30, 2009, to the Securities and Exchange Commission (SEC).

The actual financial results are detailed in the press release attached as Exhibit 99.1 to this 8-K filing. This press release is incorporated by reference, meaning it is considered part of the official filing and should be reviewed for specific financial data and commentary.

While not explicitly detailed in the 8-K form itself, the press release (Exhibit 99.1) would typically include key financial metrics for the quarter, such as revenue, net income, earnings per share (EPS), and potentially details on segment performance, guidance, and significant operational developments.

The 8-K report was signed by Robert A. Hagemann, who holds the position of Senior Vice President and Chief Financial Officer at Quest Diagnostics Incorporated.